Trilogy Capital’s iShares Russell Mid-Cap ETF IWR Stock Holding History

Trilogy Capital’s Portfolio IWR Stock Details IWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-560	Closed	-$31K	–	354
2018 Q3	$31K	Buy	560 +76	+16%	+$4.17K	﹤0.01%	233
2018 Q2	$26K	Hold	484	–	–	﹤0.01%	234
2018 Q1	$25K	Buy	+484	New	+$25.5K	﹤0.01%	209

Other funds holding IWR

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TIAA FSB Jacksonville, Florida $27.6B AUM 14.26% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Trilogy Capital's IWR Position: Q4 2018 in Review

Trilogy Capital sold out of iShares Russell Mid-Cap ETF (IWR) in Q4 2018, closing a stake of 560 shares — an estimated $31K sold.

Trilogy Capital first reported a position in IWR in Q1 2018 and held it in 3 quarters. The position peaked at $31K in Q3 2018. 746 funds tracked by Wall St. Rank hold IWR as of Q4 2018.

Trilogy Capital reported no remaining iShares Russell Mid-Cap ETF position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 560 iShares Russell Mid-Cap ETF shares in Q4 2018, an estimated $31K.
Trilogy Capital first reported a position in iShares Russell Mid-Cap ETF in Q1 2018 and held it in 3 quarters.
Trilogy Capital's iShares Russell Mid-Cap ETF position peaked at $31K in Q3 2018.
746 funds tracked by Wall St. Rank held iShares Russell Mid-Cap ETF as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.